Lomerizine Hydrochloride

Lomerizine hydrochloride, 101477-54-7, Lomerizine dihydrochloride, Lomerizine HCl, KB-2796, Terranas, LOMERIZINE 2HCL, 1-(bis(4-fluorophenyl)methyl)-4-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride, 1-[BIS(4-FLUOROPHENYL)METHYL]-4-(2,3,4-TRIMETHOXYBENZYL)PIPERAZINE DIHYDROCHLORIDE, 1-[bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]piperazine dihydrochloride, 3W473D5LIY, DTXSID1046427, 1-(Bis(4-fluorophenyl)methyl)-4-((2,3,4-trimethoxyphenyl)methyl)piperazine dihydrochloride, 1-(2,3,4-Trimethoxybenzyl)-4-(bis(4-fluorophenyl)methyl)piperazine dihydrochloride, Lomerizine hydrochloride (JAN), DTXCID9026427, LOMERIZINE HYDROCHLORIDE [JAN], KB 2796, CAS-101477-54-7, NCGC00164543-01, UNII-3W473D5LIY, Migsis, 1-(2,3,4-trimethoxybenzyl)-4-[bis(4-fluorophenyl)methyl]piperazine dihydrochloride, Terranas (TN), MFCD01703867, Lomerizine Hydrochlortde, SCHEMBL1153647, CHEMBL2356978, HY-B0768A, Lomerizine Dihydrochloride, 98%, BCP12061, Tox21_112172, DE-090, s4084, AKOS015900365, Tox21_112172_1, AC-2040, CCG-269965, LOMERIZINE DIHYDROCHLORIDE [MI], LOMERIZINE HYDROCHLORIDE [MART.], LOMERIZINE HYDROCHLORIDE [WHO-DD], NCGC00164543-02, AS-74676, Piperazine, 1-(bis(4-fluorophenyl)methyl)-4-((2,3,4-trimethoxyphenyl)methyl)-, dihydrochloride, CS-0012057, FT-0627971, L0245, SW197640-2, A16599, D02633, T71528, A800394, J-000407, Lomerizine dihydrochloride, >=98% (HPLC), powder, 101477-54-7, 101477-55-8(free base), Q27258118, 1-[bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]piperazine;dihydrochloride, 1-[bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]piperazine Hydrochloride Terranas Migsis

Lomerizine Hydrochloride is  classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate